These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28668681)

  • 1. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malarial protease inhibitors: potential new chemotherapeutic agents.
    Sharma A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Discovery and Development of Antimalarial Agents: Recent Advances.
    Thota S; Yerra R
    Curr Protein Pept Sci; 2016; 17(3):275-9. PubMed ID: 26796302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.
    Bobrovs R; Jaudzems K; Jirgensons A
    J Med Chem; 2019 Oct; 62(20):8931-8950. PubMed ID: 31062983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors Interactions.
    Miller Iii WA; Teye J; Achieng AO; Mogire RM; Akala H; Ong'echa JM; Rathi B; Durvasula R; Kempaiah P; Kwofie SK
    Curr Top Med Chem; 2019; 18(23):2022-2028. PubMed ID: 30499404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches in antimalarial drug discovery and development: a review.
    Aguiar AC; Rocha EM; Souza NB; França TC; Krettli AU
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):831-45. PubMed ID: 23147137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of antimalarial drug research with special reference to application of QSAR models.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Targets for Malarial Chemotherapy: A Review.
    Yadav DK; Kumar S; Teli MK; Yadav R; Chaudhary S
    Curr Top Med Chem; 2019; 19(10):861-873. PubMed ID: 31161990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state of the art in anti-malarial drug discovery and development.
    Burrows JN; Chibale K; Wells TN
    Curr Top Med Chem; 2011; 11(10):1226-54. PubMed ID: 21401508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteases of malaria parasites: new targets for chemotherapy.
    Rosenthal PJ
    Emerg Infect Dis; 1998; 4(1):49-57. PubMed ID: 9452398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting protein kinases in the malaria parasite: update of an antimalarial drug target.
    Zhang VM; Chavchich M; Waters NC
    Curr Top Med Chem; 2012; 12(5):456-72. PubMed ID: 22242850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systems biology approach to antimalarial drug discovery.
    Cortopassi WA; Celmar Costa Franca T; Krettli AU
    Expert Opin Drug Discov; 2018 Jul; 13(7):617-626. PubMed ID: 29737894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio.
    Chaparro MJ; Calderón F; Castañeda P; Fernández-Alvaro E; Gabarró R; Gamo FJ; Gómez-Lorenzo MG; Martín J; Fernández E
    ACS Infect Dis; 2018 Apr; 4(4):568-576. PubMed ID: 29320160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in the identification and development of anti-malarial agents using virtual screening based approaches.
    Shah P; Tiwari S; Siddiqi MI
    Comb Chem High Throughput Screen; 2015; 18(3):257-68. PubMed ID: 25747437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent patent reviews on small molecule-based antimalarial drugs.
    Elsohly MA; Gul W
    Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):222-32. PubMed ID: 18221180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.